GO:0042806 fucose binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042806 fucose binding is a molecular function defined as binding to fucose, the pentose 6-deoxygalactose.
• Fucose-binding proteins include lectins from bacteria, fungi, viruses, and humans that recognize fucose in glycans, glycoproteins, and glycolipids [1, 3, 5, 6].
• Fucose binding underlies host-pathogen interactions, immune recognition, and glycan-mediated signaling, with examples in norovirus, Pseudomonas aeruginosa, Aspergillus fumigatus, and SARS-CoV-2 [2, 5, 6, 8].
• Fucose-binding lectins are studied for biomedical applications such as diagnostics, anti-adhesion therapeutics, and glycan array profiling [1, 7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of fucose-binding proteins in disease and infection [1, 4, 7].
• EDITGENE provides custom cell models and CRISPR library screening to accelerate fucose-binding research.
Description
Fucose binding (GO:0042806) is a molecular function that describes the selective non-covalent interaction with fucose, a 6-deoxygalactose pentose sugar. This function is central to glycan recognition in diverse biological contexts, from bacterial adhesion to viral entry and immune modulation [2, 3, 5]. Fucose is a common terminal modification on glycoproteins and glycolipids, and its recognition by lectins and other fucose-binding proteins mediates key processes such as host-pathogen attachment, cell-cell communication, and immune surveillance [1, 6]. Researchers study fucose binding to understand infection mechanisms, develop glycan-based therapeutics, and engineer cell models for drug discovery [4, 7]. The specificity and affinity of fucose-binding proteins are often characterized using glycan arrays, surface plasmon resonance, and isothermal titration calorimetry [1, 6]. Recent work highlights that fucose binding can modulate mechanical properties of viruses and influence antibody reactivity, underscoring its broad relevance [2, 8].
fucose binding At A Glance
| GO ID | GO:0042806 |
|---|---|
| GO term | fucose binding |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Binding to fucose, the pentose 6-deoxygalactose. |
| Major function | Recognition of fucose-containing glycans on proteins and lipids |
| Examples | Bacterial lectins (LecB), fungal lectins (AFL), viral capsid proteins, human lectins |
| Related diseases | Infection, inflammation, cancer, immune disorders |
| Research methods | Glycan arrays, SPR, ITC, CRISPR screens, lectin histochemistry |
What Is GO:0042806?
According to the Gene Ontology, GO:0042806 fucose binding is the molecular function of selectively interacting with fucose, the pentose 6-deoxygalactose. This binding is non-covalent and typically involves hydrogen bonding and hydrophobic interactions with the fucose ring. It is distinct from binding to other sugars such as galactose or sialic acid, although some proteins may cross-react [1, 3].
Why Is fucose binding Important in Cell Biology?
Fucose binding is important because fucose is a terminal glycan modification that serves as a recognition signal in many physiological and pathological processes [1, 3]. Fucose-binding proteins mediate bacterial and viral adhesion to host cells, influence immune cell activation, and can be exploited for targeted therapeutics [5, 6, 8]. Understanding fucose binding at the molecular level informs the design of glycomimetic drugs, vaccines, and diagnostic tools [4, 7].
• Mediates host-pathogen interactions, including bacterial and viral attachment [2, 6].
• Regulates immune responses through lectin-mediated recognition of fucosylated antigens [5, 7].
• Involved in cancer progression and metastasis via altered fucosylation [1, 7].
• Target for anti-adhesion therapies against Pseudomonas aeruginosa and other pathogens.
• Modulates antibody reactivity and viral mechanical properties [2, 8].
• Enables glycan array-based profiling of lectin specificity [1, 3].
• Provides tools for stem cell research and regenerative medicine.
• Facilitates development of fucose-based diagnostics and biosensors [1, 7].
• Impacts gut microbiome and enteroid models of infection.
• Offers insights into blood group antigen recognition.
Molecular Mechanism of fucose binding
Fucose recognition and binding site architecture
In simple terms: Fucose-binding proteins have a pocket that fits fucose like a lock and key.
Fucose-binding proteins typically contain a carbohydrate-recognition domain (CRD) that forms hydrogen bonds with the hydroxyl groups of fucose and hydrophobic interactions with its methyl group [1, 6]. For example, the bacterial lectin LecB from Pseudomonas aeruginosa has a high-affinity fucose-binding site with a dissociation constant in the nanomolar range. Fungal lectins such as Aspergillus fumigatus fucose-specific lectin (AFL) also exhibit specific binding to fucose-containing glycans. The binding site architecture determines specificity for fucose over other sugars like galactose.
Multivalent interactions and avidity
In simple terms: Many fucose-binding proteins have multiple binding sites, making them stick more strongly.
Multivalency enhances fucose binding through avidity effects. For instance, the fucose-binding superlectin from Enterobacter cloacae exhibits high specificity for Lewis and ABO blood group antigens due to multiple binding sites. Similarly, norovirus capsid proteins engage in multivalent interactions with fucosylated histo-blood group antigens, which can cancel out mechanical differences between strains. These multivalent interactions are critical for pathogen adhesion and immune recognition.
Structural and mechanical consequences of fucose binding
In simple terms: When fucose binds, it can change the shape or stiffness of the protein or virus.
Fucose binding can induce conformational changes or alter mechanical properties. For example, fucose binding cancels out mechanical differences between distinct human noroviruses, as measured by atomic force microscopy. In SARS-CoV-2, sialic acid and fucose residues on the receptor-binding domain modulate IgG antibody reactivity, suggesting that fucose binding affects immune recognition. These structural effects are studied using X-ray crystallography, cryo-EM, and biophysical assays [1, 6].
Regulation of fucose binding by glycoconjugate presentation
In simple terms: The way fucose is presented on a cell surface affects how well it is bound.
Fucose binding is regulated by the density, spacing, and context of fucose residues on glycoproteins and glycolipids. Mucin core glycopeptides with fucose motifs impact bacterial lectin recognition, as shown by Behren et al.. Fucose-galactose polymers can inhibit cholera toxin binding to fucosylated structures, demonstrating that synthetic glycans can modulate fucose-dependent interactions. Thus, the glycan environment is a key determinant of fucose-binding specificity and avidity [3, 4].
Key Genes Involved in GO:0042806 fucose binding
The following genes and proteins are representative examples of fucose-binding molecules studied in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LecB (PA-IIL) | High-affinity fucose-binding lectin from Pseudomonas aeruginosa | Target for anti-adhesion therapeutics; model for lectin specificity |
| AFL | Fucose-specific lectin from Aspergillus fumigatus | Immune response stimulation; fungal infection diagnostics |
| Norovirus capsid protein | Binds fucosylated histo-blood group antigens | Viral entry and mechanical properties |
| SARS-CoV-2 RBD | Binds fucose and sialic acid residues | Antibody reactivity modulation |
| Cholera toxin B subunit | Binds fucosylated structures | Inhibition by fucose-galactose polymers |
| Enterobacter cloacae superlectin | High specificity for Lewis and ABO antigens | Blood group antigen recognition |
| FUT1 (H enzyme) | Fucosyltransferase that creates H antigen | Blood group and cancer research |
| FUT2 (Secretor enzyme) | Fucosyltransferase for secretor status | Host-microbe interactions |
| FUT3 (Lewis enzyme) | Fucosyltransferase for Lewis antigens | Inflammation and cancer |
| FUT4 (CD15) | Fucosyltransferase for sialyl Lewis X | Leukocyte adhesion |
| FUT7 | Fucosyltransferase for selectin ligands | Immune cell trafficking |
| FUT8 | Fucosyltransferase for core fucosylation | Antibody function and cancer |
| FUT9 | Fucosyltransferase for Lewis X | Neural development |
| FUT10 | Fucosyltransferase for O-fucose | Notch signaling |
| FUT11 | Fucosyltransferase for O-fucose | Notch signaling |
| POFUT1 | Protein O-fucosyltransferase 1 | Notch signaling and development |
| POFUT2 | Protein O-fucosyltransferase 2 | Thrombospondin type 1 repeats |
| FucT-VII | Alpha-1,3-fucosyltransferase | Selectin ligand synthesis |
How Is fucose binding Regulated?
Fucose binding is regulated at multiple levels, including the expression of fucosyltransferases that determine the presence of fucose on glycans, the availability of GDP-fucose as a substrate, and the presentation of fucosylated ligands on cell surfaces [1, 3]. For example, fucosyltransferase FUT8 regulates core fucosylation of antibodies, affecting their binding to Fc receptors. In bacteria, fucose-binding lectin expression can be induced by environmental cues. Additionally, synthetic fucose-galactose polymers can competitively inhibit fucose binding, as shown for cholera toxin.
fucose binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LecB | Pseudomonas aeruginosa infection | KO in P. aeruginosa; human lung epithelial cells |
| AFL | Aspergillosis | KO in A. fumigatus; macrophage infection model |
| Norovirus capsid | Gastroenteritis | Point mutations in capsid; human intestinal enteroids |
| FUT8 | Cancer, antibody therapy | KO in CHO cells; glycoengineered antibodies |
| FUT2 | Crohn's disease, norovirus susceptibility | Knock-in of secretor status in enteroids |
Infectious diseases
Fucose-binding proteins are critical for the adhesion and entry of various pathogens. Pseudomonas aeruginosa uses LecB to bind fucose on host cells, contributing to biofilm formation and chronic infections. Aspergillus fumigatus fucose-specific lectin stimulates immune responses and is implicated in fungal pathogenesis. Noroviruses bind fucosylated histo-blood group antigens for cell attachment, and fucose binding affects their mechanical properties. Cholera toxin binds fucosylated structures, and inhibition of this binding by fucose-galactose polymers reduces intoxication.
Cancer and metastasis
Altered fucosylation is a hallmark of cancer, and fucose-binding lectins are used to detect cancer-associated glycan changes. For example, fucose-binding lectins from plants and fungi have been employed in histochemistry to distinguish malignant from benign tissues. The Lewis and ABO blood group antigens, which are fucosylated, are recognized by bacterial superlectins and are associated with cancer progression.
Immune and inflammatory disorders
Fucose binding modulates immune cell activation and antibody function. Sialic acid and fucose residues on the SARS-CoV-2 receptor-binding domain modulate IgG antibody reactivity, influencing neutralization. Fucose-specific lectins can stimulate immune responses, as shown for Aspergillus fumigatus lectin. Selectin-mediated leukocyte adhesion depends on fucosylated ligands, and dysregulation contributes to inflammatory diseases.
From fucose binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does LecB mediate adhesion to lung cells? | LecB knockout in Pseudomonas aeruginosa; A549 cells |
| How does fucose binding affect norovirus mechanics? | Point mutations in capsid; AFM on virus-like particles |
| Can fucose polymers inhibit cholera toxin? | Knock-in of fucosylated receptors in enteroids; toxin challenge |
| What is the role of FUT8 in antibody function? | FUT8 knockout CHO cells; Fc receptor binding assays |
| How does secretor status affect norovirus infection? | FUT2 knock-in in intestinal organoids |
| Does AFL stimulate immune response? | AFL overexpression in Aspergillus; macrophage co-culture |
How to Study the fucose binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glycan array | Binding specificity to fucosylated glycans | Profiling lectin specificity [1, 3] |
| Surface plasmon resonance | Binding affinity and kinetics | Characterizing LecB-fucose interaction |
| Isothermal titration calorimetry | Thermodynamics of binding | Quantifying fucose binding |
| CRISPR knockout screen | Host genes required for fucose binding | Identifying cholera toxin entry factors |
| Lectin histochemistry | Tissue distribution of fucosylated glycans | Cancer diagnostics |
| Atomic force microscopy | Mechanical properties of virus particles | Norovirus fucose binding effects |
| ELISA | Antibody reactivity to fucosylated antigens | SARS-CoV-2 RBD antibody modulation |
| Flow cytometry | Cell surface fucose levels | Immune cell phenotyping |
Glycan arrays and lectin profiling
Glycan arrays are used to determine the specificity of fucose-binding proteins against a library of fucosylated oligosaccharides [1, 3]. This method allows high-throughput screening of lectin binding to various fucose-containing structures, including Lewis and ABO antigens.
Biophysical characterization
Surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) measure the affinity and kinetics of fucose binding [1, 6]. These techniques provide quantitative data on dissociation constants and thermodynamic parameters, which are essential for understanding molecular recognition.
CRISPR screens and functional genomics
CRISPR knockout libraries can identify genes required for fucose binding and downstream signaling [1, 4]. For example, genome-wide screens in human cells can reveal host factors that mediate cholera toxin intoxication or norovirus entry.
Imaging and histochemistry
Fluorescently labeled fucose-binding lectins are used in imaging to detect fucosylated glycans in tissues and cells [1, 5]. Lectin histochemistry is valuable for cancer diagnostics and studying tissue-specific glycosylation.
How CRISPR Can Be Used to Study GO:0042806 fucose binding
Knockout
CRISPR knockout of fucose-binding protein genes, such as LecB in Pseudomonas aeruginosa or FUT8 in CHO cells, enables loss-of-function studies to determine their role in adhesion, infection, and glycan synthesis [6, 8]. Knockout cell lines can be used in infection assays and glycan profiling.
Point Mutation
Point mutations in fucose-binding domains can abrogate binding without affecting protein expression. For example, mutating key residues in the norovirus capsid or LecB binding site can test the contribution of specific interactions to viral mechanics or bacterial adhesion [2, 6].
Knock-in
Knock-in of fucosyltransferase genes, such as FUT2 or FUT8, into cell lines allows controlled expression of fucosylated glycans for studying pathogen binding and antibody function [3, 8]. Knock-in models can also introduce tagged fucose-binding proteins for localization studies.
Overexpression
Overexpression of fucose-binding lectins, such as AFL or LecB, in mammalian cells or bacteria can enhance binding and facilitate structural and functional studies [5, 6]. Overexpression models are useful for producing recombinant lectins for glycan array screening.
How EDITGENE Supports fucose binding Research
Researchers studying fucose binding-related genes often need to determine whether a candidate gene is causally involved in glycan recognition, infection, or immune modulation. EDITGENE provides custom CRISPR-edited cell models and screening services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for fucose binding research.
Frequently Asked Questions About fucose binding
What is fucose binding?
Fucose binding is a molecular function (GO:0042806) defined as the selective non-covalent interaction with fucose, a 6-deoxygalactose sugar.
What genes are involved in fucose binding?
Genes encoding fucose-binding lectins (e.g., LecB, AFL), fucosyltransferases (e.g., FUT1-11, POFUT1/2), and viral capsid proteins are involved [1, 5, 6].
What is the GO ID for fucose binding?
The Gene Ontology ID for fucose binding is GO:0042806.
How is fucose binding studied?
It is studied using glycan arrays, surface plasmon resonance, isothermal titration calorimetry, and CRISPR screens [1, 4, 6].
Why is fucose binding important in infection?
Fucose-binding proteins mediate pathogen adhesion and entry, as seen in Pseudomonas aeruginosa, norovirus, and cholera toxin [2, 4, 6].
What diseases are associated with fucose binding?
Infectious diseases, cancer, and immune disorders are associated with altered fucose binding [1, 5, 7].
Can CRISPR be used to study fucose binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are used to dissect fucose-binding protein function [2, 4, 8].
What are fucose-binding lectins?
Lectins are proteins that bind specific carbohydrates; fucose-binding lectins recognize fucose on glycans and are found in bacteria, fungi, and plants [1, 5, 6].
How does fucose binding affect norovirus?
Fucose binding cancels out mechanical differences between distinct human noroviruses, influencing their physical properties.
What is the role of fucose binding in cancer?
Fucose-binding lectins are used to detect cancer-associated glycan changes, and fucosylation affects metastasis [1, 7].
Conclusion
Fucose binding (GO:0042806) is a fundamental molecular function with broad implications in infection, immunity, and cancer. Understanding its mechanisms through CRISPR models and biophysical methods can lead to new diagnostics and therapeutics. EDITGENE offers comprehensive services to support fucose-binding research.
References
- 1. Nivetha R et al.. 2023. Fucose-binding lectins: purification, characterization and potential biomedical applications.. Mol Biol Rep 50(12):10589-10603 PMID: 37934371
- 2. Feng Y et al.. 2023. Fucose Binding Cancels out Mechanical Differences between Distinct Human Noroviruses.. Viruses 15(7) PMID: 37515170
- 3. Behren S et al.. 2023. Fucose Binding Motifs on Mucin Core Glycopeptides Impact Bacterial Lectin Recognition.. Angew Chem Int Ed Engl 62(32):e202302437 PMID: 37067376
- 4. Cervin J et al.. 2020. Fucose-Galactose Polymers Inhibit Cholera Toxin Binding to Fucosylated Structures and Galactose-Dependent Intoxication of Human Enteroids.. ACS Infect Dis 6(5):1192-1203 PMID: 32134631
- 5. Sakai K et al.. 2019. Fucose-specific lectin of Aspergillus fumigatus: binding properties and effects on immune response stimulation.. Med Mycol 57(1):71-83 PMID: 29370403
- 6. Gillon E et al.. 2020. LecB, a High Affinity Soluble Fucose-Binding Lectin from Pseudomonas aeruginosa.. Methods Mol Biol 2132:475-482 PMID: 32306354
- 7. Beshr G et al.. 2025. A fucose-binding superlectin from Enterobacter cloacae with high Lewis and ABO blood group antigen specificity.. J Biol Chem 301(2):108151 PMID: 39743000
- 8. Samuelsson E et al.. 2022. Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity.. ACS Infect Dis 8(9):1883-1893 PMID: 35980012
